The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sequencing bispecific antibodies and CAR T cell therapy in multiple myeloma with prior exposure to BCMA-targeted therapies.
 
Urvi Patel
Employment - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Olalekan O. Oluwole
Consulting or Advisory Role - ADC Therapeutics; Curio Science; Epizyme; Gilead Sciences; Kite/Gilead; Legend Biotech; Nektar; Novartis; Syncopation Life Sciences
Research Funding - Kite, a Gilead company (Inst)
 
Adetola Kassim
No Relationships to Disclose
 
Reena Jayani
No Relationships to Disclose
 
Paul Belliveau
No Relationships to Disclose
 
Bipin Savani
No Relationships to Disclose
 
Bhagirathbhai R. Dholaria
Stock and Other Ownership Interests - Iovance Biotherapeutics; Syndax
Honoraria - Adaptive Biotechnologies; Curio Science; MJH Healthcare Holdings, LLC; Wiley
Consulting or Advisory Role - arivan research; Beam Therapeutics; Gamida Cell; Jazz Pharmaceuticals; Pluristem Therapeutics
Research Funding - Angiocrine Bioscience (Inst); Janssen Oncology (Inst); MEI Pharma (Inst); Orca Bio (Inst); Pfizer (Inst); poseida therapeutics (Inst); Takeda (Inst); WUGEN, Inc. (Inst)